RxDoctor Payments Data

David Swanson, MD

Orthopaedic Trauma · Reno, NVNPI 1407147556

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Sequoia Surgical, Inc. at 48.0% of the total. Reporting peaked in 2021 at $1,369 and has fallen 88.0% since, to $165 in 2025.

$2,525in general payments, 2019–2025

Across 22 payments — averaging $114.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sequoia Surgical, Inc.$1K
  • Stryker$668
  • Johnson & Johnson$297
  • Exactech, Inc.$185
  • Acumed LLC$125
  • Abbott$23
  • plus $15 from 1 others
$10,860in research payments, 2019–2025

Across 5 payments — averaging $2172.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$11K

What the payments were for

  • Travel & lodging$452%
  • Food & beverage$1,28051%
  • Education$1,20048%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in Nevadato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$219,807
Medicare patients
302
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$210
Tramadol Hcl13$45
Meloxicam12$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →